Uppsala University and University Hospital
Uppsala, 751 24, Sweden
NCT Number: NCT01102920
The primary aim is to study whether a tailored behavioural medicine intervention addressing physical activity and eating habits have additional effects to continuous positive airways pressure (CPAP) in patients with moderate or severe obstructive sleep apnea syndrome (OSAS) combined with obesity. Direct everyday life consequences (see below) of OSAS are studied, as well as cognitive functions and ventilatory parameters. Long-term benefits will be examined in terms of quality of life and everyday life activity. Another aim is to study mechanisms of treatment effects, if any.
The specific goals are:
1. To study changes in OSAS ventilatory parameters following a tailored behavioural medicine intervention addressing physical activity and eating habits (including CPAP) compared to regular CPAP-treatment 2. To study immediate and long-term effects on daytime sleepiness, attention and concentration, everyday life activity, quality of life following a tailored behavioural medicine intervention addressing physical activity and eating habits (including CPAP) compared to regular CPAP-treatment 3. To study associations of changes in metabolic parameters and systemic inflammation and physical activity level and adherence to CPAP-regimen respectively. 4. To identify mediators, moderators, and predictors of treatment effects, if any.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Not applicable
Uppsala, 751 24, Sweden
OSAS is characterised by loud snoring, upper airway obstruction, and occasional apnea during sleep. OSAS may affect at least 4% of the men and 2% of the women in middle-age. In Sweden, prevalence figures of 200 000 have been reported. The mechanisms behind OSAS is not fully explained but functionally impaired upper airways muscles, causing a reduction in tonic and phasic contraction during sleep, are proposed one key explanation. The reduced contractions cause partial or complete occlusion of airflow, which in turn cause oxygen desaturation and sleep fragmentation. Patients commonly report everyday life consequences including loud snoring, sleep disturbances, daytime sleepiness, reduced alertness and concentration, and involvement in motor vehicle accidents. Between 7% and 70% of patients suffer from depression and anxiety (figures vary extensively because of methodological differences in existing studies). Due to cardiovascular consequences, OSAS is also linked to hypertension, myocardial infarction, and stroke. Approximately 75% of patients with severe OSAS carry overweight. First line measures recommended for OSAS are conservative including lifestyle modifications, CPAP, and oral appliances. Current state-of-science concludes that CPAP is best possible evidence-based treatment. Despite the use of life style modification recommendations in terms of physical activity and weight loss in accepted guidelines of OSAS, randomised clinical trials supporting these recommendations are rare. Hence, the value of health behaviour modifications has yet to be established. Research within this area is therefore of major interest and urgency, which has motivated the present study design.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
8-10 sessions, 2-4 booster sessions Behavioural protocol in seven steps to initiate, carry out and maintain health-enhancing physical activity and sound eating habits.
Steps are standardized including: progressive goal setting, self-monitoring, functional behavioural analysis, skills training (basic and applied), generalization, and maintenance and relapse prevention. Content within each step is tailored to individual expectations and skills.
Treatments are provided by a physical therapist and a dietician.
CPAP-treatment as usual (during nights)
Time frame: Baseline, immediate post-treatment, 18-month follow-up
Ventilatory monitoring at night. Oxygen saturation continuously measured by a pulse oximeter. The following parameters are analysed:
Time frame: Baseline, immediate post-treatment, 18-month follow-up
Epworths sleepiness scale
Time frame: Baseline, immediate post-treatment, 18-month follow-up
Time frame: Baseline, immediate post-treatment, 18-month follow-up
SF-36
Time frame: Baseline, immediate post-treatment, 18-month follow-up
The Patient Goal Priority Questionnaire
Time frame: Baseline, immediate post-treatment, 18-month follow-up
Time frame: Baseline, immediate post-treatment, 18-month follow-up
6 minutes walking distance
Time frame: Baseline, immediate post-treatment, 18-month follow-up
Dutch eating behaviour questionnaire
Time frame: Baseline, mid-treatment, immediate post-treatment, 18-month follow-up
Time frame: Baseline, immediate post-treatment, 18-month follow-up
Time frame: Baseline, immediate post-treatment, 18-month follow-up
MADRS Depression scale
Time frame: Baseline, mid-treatment, immediate post-treatment, 18-month follow-up
Selected items from the Tampa Scale of Kinesiophobia
Time frame: Baseline, immediate post-treatment, 18-month follow-up
Uppsala University
Other
Health Behaviour Modifications in Obstructive Sleep Apnea. Tailored Behavioural Medicine Strategies to Promote Physical Activity and Weight Loss.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05104450
Apnea, Behavior
Seattle, Washington, United States
View Trial DetailsNCT01317329
Apnea, Body Weight
Madison, Wisconsin, United States
View Trial DetailsNCT03280914
Apnea, Behavior
Guangzhou, China
View Trial DetailsNCT02832414
Apnea, Body Weight
L'Hospitalet de Llobregat, Barcelona, Spain
View Trial Details